Ignite Creation Date:
2025-12-24 @ 3:41 PM
Ignite Modification Date:
2026-01-01 @ 9:01 PM
Study NCT ID:
NCT01536392
Status:
COMPLETED
Last Update Posted:
2021-06-11
First Post:
2012-02-16
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Oral Ondansetron Versus Transdermal Granisetron (Sancuso) for Women With Cervical, Endometrial or Vaginal Cancer Receiving Pelvic Chemoradiation
Sponsor:
M.D. Anderson Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2012-03
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-03
Completion Date Type:
ACTUAL
First Submit Date:
2012-02-16
First Submit QC Date:
None
Study First Post Date:
2012-02-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2020-12-10
Results First Submit QC Date:
None
Results First Post Date:
2021-05-17
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2020-10-20
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2021-05-18
Last Update Post Date:
2021-06-11
Last Update Post Date Type:
ACTUAL